Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001228684-25-000005

Director sold 22,946 shares at an average $81.26 ($1,864,678)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

LINK WILLIAM J PHD · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-15 Sale : show line 1 in the form 10b5-1 −5,046 $80.80 $407,717 136,286 D
2025-12-15 Sale : show line 2 in the form 10b5-1 −6,306 $81.75 $515,516 129,980 D
2025-12-15 Sale : show line 3 in the form 10b5-1 −1,148 $82.39 $94,584 128,832 D
2025-12-15 Sale : show line 4 in the form 10b5-1 −5,680 $80.71 $458,433 4,766 I
2025-12-15 Sale : show line 5 in the form 10b5-1 −4,766 $81.50 $388,429 0 I
Open-market sales · 22,946 sh · avg $81.26 · $1,864,678
Loading xslF345X05/wk-form4_1766005663.xml…